drugset
drugset / Trial / NCT05507372

Treatment for Post Acute COVID-19 Syndrome

NCT05507372 ↗

Unknown 50 enrolled Applied Biology, Inc. Jupiter Wellness, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Post-acute COVID-19 tinnitus has not been treated successfully. As tinnitus may be related to SARS-CoV-2 neurological manifestations. This study aims to investigate if the dopamine receptor antagonists can be used effectively treat COVID-19 induced tinnitus.

Timeline

Start
2022-10-01
Primary completion
2023-06-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pimozide Small molecule 1 mg Oral

Indications

tinnitus